Wilson JM - Search Results

1

Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs.

Yang Y, Su Q, Wilson JM. Yang Y, et al. Among authors: wilson jm. J Virol. 1996 Oct;70(10):7209-12. doi: 10.1128/JVI.70.10.7209-7212.1996. J Virol. 1996. PMID: 8794368 Free PMC article.

2

Submucosal glands are the predominant site of CFTR expression in the human bronchus.

Engelhardt JF, Yankaskas JR, Ernst SA, Yang Y, Marino CR, Boucher RC, Cohn JA, Wilson JM. Engelhardt JF, et al. Among authors: wilson jm. Nat Genet. 1992 Nov;2(3):240-8. doi: 10.1038/ng1192-240. Nat Genet. 1992. PMID: 1285365

3

Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: biological efficacy study.

Engelhardt JF, Simon RH, Yang Y, Zepeda M, Weber-Pendleton S, Doranz B, Grossman M, Wilson JM. Engelhardt JF, et al. Among authors: wilson jm. Hum Gene Ther. 1993 Dec;4(6):759-69. doi: 10.1089/hum.1993.4.6-759. Hum Gene Ther. 1993. PMID: 7514445 Free article.

4

Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: toxicity study.

Simon RH, Engelhardt JF, Yang Y, Zepeda M, Weber-Pendleton S, Grossman M, Wilson JM. Simon RH, et al. Among authors: wilson jm. Hum Gene Ther. 1993 Dec;4(6):771-80. doi: 10.1089/hum.1993.4.6-771. Hum Gene Ther. 1993. PMID: 7514446 Free article.

5

Ultrastructural localization of variant forms of cystic fibrosis transmembrane conductance regulator in human bronchial epithelial of xenografts.

Yang Y, Engelhardt JF, Wilson JM. Yang Y, et al. Among authors: wilson jm. Am J Respir Cell Mol Biol. 1994 Jul;11(1):7-15. doi: 10.1165/ajrcmb.11.1.7517144. Am J Respir Cell Mol Biol. 1994. PMID: 7517144

6

Gene therapy of cystic fibrosis lung disease using E1 deleted adenoviruses: a phase I trial.

Wilson JM, Engelhardt JF, Grossman M, Simon RH, Yang Y. Wilson JM, et al. Hum Gene Ther. 1994 Apr;5(4):501-19. doi: 10.1089/hum.1994.5.4-501. Hum Gene Ther. 1994. PMID: 7519452 Clinical Trial. No abstract available.

7

Gene therapy for cystic fibrosis using E1-deleted adenovirus: a phase I trial in the nasal cavity. The University of North Carolina at Chapel Hill.

Boucher RC, Knowles MR, Johnson LG, Olsen JC, Pickles R, Wilson JM, Engelhardt J, Yang Y, Grossman M. Boucher RC, et al. Among authors: wilson jm. Hum Gene Ther. 1994 May;5(5):615-39. doi: 10.1089/hum.1994.5.5-615. Hum Gene Ther. 1994. PMID: 7519885 Clinical Trial.

8

Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis.

Yang Y, Nunes FA, Berencsi K, Gönczöl E, Engelhardt JF, Wilson JM. Yang Y, et al. Among authors: wilson jm. Nat Genet. 1994 Jul;7(3):362-9. doi: 10.1038/ng0794-362. Nat Genet. 1994. PMID: 7522742

9

MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses.

Yang Y, Ertl HC, Wilson JM. Yang Y, et al. Among authors: wilson jm. Immunity. 1994 Aug;1(5):433-42. doi: 10.1016/1074-7613(94)90074-4. Immunity. 1994. PMID: 7533647

10

Expression of alpha v beta 5 integrin is necessary for efficient adenovirus-mediated gene transfer in the human airway.

Goldman MJ, Wilson JM. Goldman MJ, et al. Among authors: wilson jm. J Virol. 1995 Oct;69(10):5951-8. doi: 10.1128/JVI.69.10.5951-5958.1995. J Virol. 1995. PMID: 7545239 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,858 results

Search Page

Filters